IGF2BP3 and melanoma: Then, IGF2BP3 mRNA expression was proved to be an independent prognostic factor for DMFS (HR, 1.016; 95% CI: 1.005–1.028; p = 0.004) and MSS (HR, 1.024; 95% CI: 1.001–1.048; p = 0.044) together with thicker and ulcerated melanomas.